Natco Pharma Limited — Dividend/Bonus, 12-11-2024: Dividend

NATCO Pharma Limited has declared a second interim dividend of ₹1.50 per equity share for FY 2024-25. The record date for this dividend is set for November 25, 2024, with payments commencing on December 2, 2024. In its unaudited financial results for the quarter and half-year ended September 30, 2024, NATCO reported a consolidated revenue of ₹1,434.9 crore, up 35.3% year-on-year, and a net profit of ₹676.5 crore, reflecting an impressive growth of 83%. The results were bolstered by strong export traction and a stable domestic pharmaceutical business.